Erectile dysfunction prevalence higher in HIV-infected men

July 12, 2012
Erectile dysfunction prevalence higher in HIV-infected men
HIV infection in men is a strong, independent predictor of erectile dysfunction, regardless of age and body mass index, according to a study published in the July issue of The Journal of Sexual Medicine.

(HealthDay) -- HIV infection in men is a strong, independent predictor of erectile dysfunction (ED), regardless of age and body mass index (BMI), according to a study published in the July issue of The Journal of Sexual Medicine.

Stefano Zona, M.D., of the University of Modena and Reggio Emilia in Italy, and associates compared the prevalence of ED among young to middle-aged HIV-infected (444) and HIV-uninfected (71) men. ED was assessed using the International Index of Erectile Function questionnaire. Participants' serum testosterone; demographic characteristics; and their age, weight, height, and BMI were obtained.

The researchers found that, compared with HIV-uninfected men, HIV-infected men of all decades of age had a higher prevalence of mild, moderate, and severe ED. correlated significantly with ED in univariate analysis (odds ratio, 34.19) and remained the strongest predictor of ED in multivariate analysis (odds ratio, 42.26), after adjustment for age and BMI.

"This study shows an increased ED prevalence in HIV-infected individuals and suggests that this condition is intrinsic in the clinical presentation of HIV infection," the authors write. "The onset of ED seems to occur earlier in HIV-infected men than in HIV-uninfected men, an aspect of clinical relevance when managing these patients."

Explore further: HIV raises anal cancer risk in women, study says

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

HIV raises anal cancer risk in women, study says

April 16, 2012
(HealthDay) -- Women with HIV are at increased risk for anal cancer, a new study finds.

Earlier male circumcision may help to slow rates of HIV, HPV transmission in South Africa

October 6, 2011
According to Anna R. Giuliano, Ph.D., program leader in cancer epidemiology at Moffitt Cancer Center in Tampa, Fla., and colleagues in the Netherlands, earlier circumcision of males in South Africa may be a positive step ...

Recommended for you

Researchers find latent HIV reservoirs inherently resistant to elimination by CD8+ T-cells

January 22, 2018
The latest "kick-and-kill" research to eliminate the HIV virus uncovered a potential obstacle in finding a cure. A recent study by researchers at the George Washington University (GW) found that latent HIV reservoirs show ...

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.